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Abstract
The objective was to describe time trends in cervi-
cal cancer mortality rates in Brazil as a whole and 
in the country’s major geographic regions and 
States from 1980 to 2009. This was an ecological 
time series study using data recorded in the Mor-
tality Information System (SIM) and census data 
collected by the Brazilian Institute of Geography 
and Statistics (IBGE). Analysis of mortality trends 
was performed using Poisson regression. Cervical 
cancer mortality rates in Brazil tended to stabi-
lize. In the geographic regions, a downward trend 
was observed in the South (-4.1%), Southeast 
(-3.3%), and Central-West (-1%) and an upward 
trend in the Northeast (3.5%) and North (2.7%). 
The largest decreases were observed in the States 
of São Paulo ( 5.1%), Rio Grande do Sul, Espírito 
Santo, and Paraná (-4.0%). The largest increases 
in mortality trends occurred in Paraíba (12.4%), 
Maranhão (9.8%), and Tocantins (8.9%). Cervical 
cancer mortality rates stabilized in the country 
as a whole, but there was a downward trend in 
three geographic regions and 10 States, while two 
geographic regions and another 10 States showed 
increasing rates. 
Uterine Cervical Neoplasms; Mortality; 
Mortality Rate 
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Resumo
O objetivo deste estudo foi fornecer um quadro 
quanto à tendência da mortalidade por câncer 
do colo de útero no Brasil, em suas regiões e es-
tados, entre 1980 e 2009. Estudo ecológico de sé-
rie temporal, com uso de informações sobre óbi-
tos (Sistema de Informações sobre Mortalidade 
– SIM) e base demográfica (Instituto Brasileiro 
de Geografia e Estatística – IBGE). Foram reali-
zadas análises das tendências da mortalidade 
por meio da regressão de Poisson. Houve estabi-
lização nas taxas de mortalidade no Brasil. Nas 
regiões, houve queda no Sul (-4,1%), Sudeste 
(-3,3%) e Centro-Oeste (-1%); aumento no Nor-
deste (3,5%) e Norte (2,7%). As maiores reduções 
foram observadas em São Paulo (-5,1%), Rio 
Grande do Sul, Espírito Santo e Paraná (-4,0%). 
Os maiores aumentos foram observados na Pa-
raíba (12,4%), Maranhão (9,8%) e Tocantins 
(8,9%). No Brasil, houve estabilização na mor-
talidade por câncer do colo do útero. No entan-
to, houve redução em 3 regiões e em 10 estados, 
enquanto, em 2 regiões e em outros 10 estados, 
a mortalidade segue aumentando. Uma das 
razões para essa disparidade pode ser o menor 
acesso ao tratamento para as pacientes de áreas 
menos desenvolvidas.
Neoplasias do Colo do Útero; Mortalidade; 
Coeficiente de Mortalidade
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Introduction
Uterine cervical cancer is the third most common 
type of cancer and the fourth cause of death from 
cancer in women worldwide, accounting for 9% 
(529,800) of all new cancer cases in women in 2008 
and 8% (275,100) of all the deaths 1. More than 
85% of cases and deaths occurred in developing 
countries, and the following are thus considered 
high-risk regions: East and West Africa (incidence 
> 30/100,000), South Africa (26.8/100,000), South-
Central Asia (24.6/100,000), and South and Cen-
tral America (23.0/100,000) 2. The incidence rates 
are lower in West Asia, North America, and Aus-
tralia (< 6/100,000).
Most cases of cervical cancer are associated 
with extrinsic, environmental, and lifestyle fac-
tors 3. The principal risk factors associated with 
cervical cancer include human papillomavirus 
virus (HPV), early sexual initiation (< 16 years), 
numerous sex partners (more than four), genital 
warts, and smoking 4. This calls attention to the 
potential use of measures to avert these risk fac-
tors and thus decrease the incidence of cervical 
cancer. However, it is not easy to change a popula-
tion’s lifestyle, especially in the midst of poverty 
and insufficient schooling 3.
The advent of Pap smear screening some 50 
years ago resulted in a 50-70% drop in mortality 
rates from cancer cervical 5.
According to the World Health Organiza-
tion (WHO), 80% to 100% coverage of the target 
population with Pap smear screening and an 
organized network for adequate diagnosis and 
treatment would allow a 60% to 90% reduction 
in invasive cervical cancer 6. High cervical cancer 
rates in developing countries and in poor popu-
lations are due largely to lack of screening (which 
would allow early-stage detection) 1.
In the United States, the expected number of 
new cervical cancer cases in 2011 was 12,710, with 
an estimated 4,290 deaths 7. In Brazil, the expect-
ed number of new cases in 2012 is 17,540, with 
an estimated risk of 17 cases per 100 thousand 
women 8. There were a total of 5,063 reported 
deaths in 2009 (Departamento de Informática do 
SUS. http://www2.datasus.gov.br/DATASUS/in
dex.php?area=0205, accessed on 14/May/2011). 
However, little is known about cervical cancer 
mortality trends in Brazil.
Mortality data allow continuous monitoring 
of vital events and the development of health in-
dicators 9. The quality of data on deaths in Bra-
zil was classified as average in 2000 10. However, 
there are considerable differences in the degree of 
data comprehensiveness in the records 8,11. Most 
of States in the North and Northeast regions pres-
ent high levels of underreporting of deaths and a 
high proportion of ill-defined causes 12,13. Begin-
ning in 2004, the Ministry of Health implemented 
the Program to Reduce the Percentage of Deaths 
with Ill-Defined Causes in the North and North-
east, and in 2008 it launched the implementation 
of verbal autopsy in Brazil as a method for inves-
tigation of deaths from ill-defined causes 14.
Importantly, verbal autopsy makes key con-
tributions, including questions on family com-
position as well as occupation and habits like 
smoking and alcohol consumption. Insofar as 
possible, the family reports the disease history 
for the deceased individual. According to Article 
77 of Brazil’s Law 6,015 of December 31, 1973, 
amended by Law 6,216, of June 30, 1975, “No 
burial may be performed without a death cer-
tificate issued by the notary public of the place of 
death, having recorded the place of death, based on 
the physician’s report, if there be one in said place, 
or else by two qualified persons who have witnessed 
or verified the death” 15. We should thus use verbal 
autopsies with caution; according to the WHO, 
this recourse is only justified when all other in-
vestigative methods have been attempted 6.
More detailed epidemiological knowledge on 
cervical cancer mortality in Brazil should provide 
a scientific basis for planning public policies and 
clinical trials that can be implemented in a more 
structured and effective way for early detection 
and treatment. The aim of this study was thus to 
analyze time trends in cervical cancer mortality 
in Brazil as a whole and in its major geographic 
regions and States from 1980 to 2009.
Methods
Study design
This was an ecological time series study using 
data on deaths from cervical cancer in Brazilian 
women from 1980 to 2009.
Study area
Brazil, located in South America, has a total ter-
ritory of 8,514,876km2, with a political and ad-
ministrative division comprising 26 States and 
the Federal district, distributed in five major geo-
graphic regions (South, Southeast, Central-West, 
North, and Northeast) which display different 
human development indices or HDI (Instituto 
Brasileiro de Geografia and Estatística. http://
www.ibge.gov.br, accessed on Mar/2012).
The Brazilian population in 2010 was 
190,755,799, with 96.0 men for every 100 women 
and a mean population density of 22.5 inhabit-
ants per square kilometer (Instituto Brasileiro de 
TRENDS IN CERVIX CANCER MORTALITY 601
Cad. Saúde Pública, Rio de Janeiro, 29(3):599-608, mar, 2013
Geografia and Estatística. http://www.ibge.gov.
br, accessed on Mar/2012).
Data collection and analysis
Data on deaths from cervical cancer were col-
lected from the Mortality Information System 
or SIM (Departamento de Informática do SUS. 
http://www2.datasus.gov.br/DATASUS/index.
php?area=0205, accessed on 14/May/2011). Pop-
ulation data were obtained from the Brazilian 
Institute of Geography and Statistics [Instituto 
Brasileiro de Geografia and Estatística – IBGE] 
(http://www.ibge.gov.br).
The study included deaths from cervical can-
cer in Brazilian women over 20 years of age and 
excluded cases with unknown or missing age.
Statistical methods
The crude cervical cancer mortality rate was cal-
culated as the number of deaths of residents di-
vided by the total population residing in a given 
geographic area in the given year (x 100,000).
Age-standardized mortality was calculated 
using the indirect method, with a Segi world 
population as the reference 16.
Identification of significant changes in mor-
tality trends used the Poisson regression model 17 
based on Joinpoint, version 3.4.3 (National Cancer
Institute; http://www.surveillance.cancer.gov/
joinpoint). This study used a maximum number 
of 01 joinpoint. The trend in each period was de-
scribed by obtaining the annual percent change 
(APC), with a 95% confidence interval (95%CI) 
and significance set at p < 0.05.
DATASUS, the Information Technology De-
partment of the Brazilian Unified National Health 
System, makes available the databases from the 
SIM and the IBGE. These are secondary, public-
domain data, so there was no need for approval 
by an Ethics and Research Committee.
Results
From 1980 to 2009, a total of 100,788 deaths from 
cervical cancer were reported in Brazilian wom-
en. The North was the region with the highest 
mortality coefficient (9.9/100,000 women), fol-
lowed by the Central-West (8.6/100,000), South 
(6.7/100,000), Northeast (6.3/100,000), and 
Southeast (5.2/100,000) (Figure 1). In the States, 
the cervical cancer mortality rates showed the 
same profile as the respective regions, and the 
widest variations were seen in the States of the 
North (Figure 2).
The mortality trend analysis for Brazil as a 
whole showed a stabilization (Table 1), with APC 
varying from 0.2% (1980 to 2005) to  2.2%, without 
Figure 1
Cervical cancer mortality rates in the major geographic regions of Brazil from 1980 to 2009.
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Figure 2
Cervical cancer mortality rates in the States of Brazil and Federal District from 1980 to 2009.
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(continues)
statistical significance until 2009. In the country’s 
major geographic regions, there was a downward 
trend in the South (APC = -4.1%) beginning in 
1999, Southeast (APC = -3.3%) from 2001 to 2009, 
and Central-West (APC = -1%) during the study 
period, while the Northeast (APC = 3.5%) and 
North (APC = 2.7%) showed an upward trend in 
mortality.
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Figure 2 (continued)
(continues)
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As for the mortality trends by State (Table 
2), there was a significant downward trend in 10 
States, São Paulo (APC = -5.1%), Rio Grande do Sul 
(APC = -4%), Espírito Santo (APC = -4%), Paraná 
(APC = 3.9%), Santa Catarina (APC = -3.4%), Dis-
trito Federal (APC = -3.3%), Amapá (APC = -2.8%), 
Goiás (APC = -1.4%), Rio Grande do North (APC 
= -1%), and Minas Gerais (APC = -0.6%), and a 
non-significant reduction in Rio de Janeiro and 
Mato Grosso do Sul.
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Figure 2 (continued)
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Note: the States and Federal District are grouped in the offi cial major geographic regions.
AC: Acre; AL: Alagoas; AM: Amazonas; AP: Amapá; BA: Bahia; CE: Ceará; DF: Federal District; ES: Espírito Santo; GO: Goiás; MA: Maranhão; 
MG: Minas Gerais; MT: Mato Grosso; MS: Mato Grosso do Sul; PA: Pará; PB: Paraíba; PE: Pernambuco; PI: Piauí; PR: Paraná; RJ: Rio de Janeiro; 
RO: Rondônia; RN: Rio Grande do Norte; RS: Rio Grande do Sul; RR: Roraima; SC: Santa Catarina; SE: Sergipe; SP: São Paulo; TO: Tocantins.
Table 1
Cervical cancer mortality trends from 1980 to 2009 in Brazil and its major geographic regions.
Brazil and 
regions
Trend 1 Trend 2
Period Mortality rate APC 95%CI 
(p-value)
Period Mortality rate APC 95%CI 
(p-value)Beginning End Beginning End Beginning End Beginning End
Brazil 1980 2005 5.2 5.3 0.2 -0.0; 0.4 (0.07) 2005 2009 5.3 4.8 -2.2 -5.3; 0,9 (0.12)
South 1980 1999 5.1 6.8 1.7 * 1.1; 2.3 (< 0.01) 1999 2009 6.8 4.2 -4.1 * -5.6; -2.6 (< 0.01)
Southeast 1980 2001 5.2 4.9 -0.2 -0.5; 0.1 (0.23) 2001 2009 4.9 3.6 -3.3 * -4.6; -2.1 (< 0.01)
Central-
West
1980 2009 8.0 5.9 -1.0 
*
-1.4; -0.6 (< 0.01)
North 1980 1996 8.2 6.9 -0.5 -1.4; 0.5 (0.32) 1996 2009 6.9 10.0 2.7 * 1.3; 4.1 (< 0.01)
Northeast 1980 1996 4.5 4.1 -0.6 -1.2; 0.0 (0.05) 1996 2009 4.1 5.9 3.5 * 2.6; 4.3 (< 0.01)
APC: annual percent change; 95%CI: 95% confi dence interval.
* Statistically signifi cant; p < 0.05.
Note: standardized mortality rate per 100,000 women.
The States of Mato Grosso, Amazonas, Pará, 
Roraima, Tocantins, Maranhão, Piauí, Paraíba, 
Alagoas, and Ceará showed an increase in cervi-
cal cancer mortality, the worst of which in Paraíba 
(APC = 12.4%), Maranhão (APC = 9.8%), Tocan-
tins (APC = 8.9%), and Piauí (APC = 6.6%).
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Table 2
Cervical cancer mortality trends from 1980 to 2009 in the States of Brazil and Federal District.
State Trend 1 Trend 2
Period Mortality rate APC 95%CI (p-value) Period Mortality rate APC 95%CI (p-value)
Beginning End Beginning End Beginning End Beginning End
PR 1980 1999 5.4 7.5 1.7 * 0.9; 2.5 (< 0.01) 1999 2009 7.5 4.4 -3.9 * -5.9; -1.8 (< 0.01)
SC 1980 1998 3.5 5.6 2.8 * 1.5; 4.1 (< 0.01) 1998 2009 5.6 3.9 -3.4 * -6.0; -0.8 (0.01)
RS 1980 1998 5.4 6.9 1.7 * 0.9; 2.6 (< 0.01) 1998 2009 6.9 4.1 -4.0 * -5.6; -2.3; (< 0.01)
ES 1980 1999 3.2 7.5 2.8 * 1.4; 4.2 (< 0.01) 1999 2009 7.5 4.2 -4.0 * -7.5; -0.4 (0.03)
RJ 1980 2004 5.3 6.3 0.6 * 0.1; 1.2 (0.02) 2004 2009 6.3 4.8 -3.0 -8.3; 2.7 (0.28)
SP 1980 2001 5.7 4.7 -0.6 * -1.0; -0.3 (< 0.01) 2001 2009 4.7 3.2 -5.1 * -6.5; -3.8 (< 0.01)
MG 1980 2009 4.4 3.2 -0.6 * -1.0; -0.3 (< 0.01)
GO 1980 2009 8.4 5.9 -1.4 * -2.0; -0.7 (< 0.01)
MS 1980 2009 8.5 7.5 -0.1 -0.7; 0.5 (0.82)
MT 1980 2009 0.5 5.6 3.4 * 1.3; 5.5 (< 0.01)
DF 1980 2009 12.8 5.1 -3.3 * -4.0; -2.6 (< 0.01)
AM 1980 2009 5.5 15.5 2.5 * 1.4; 3.5 (< 0.01)
PA 1980 1998 10.0 5.9 -1.5 * -2.5; -0.6 (< 0.01) 1998 2009 5.9 9.6 2.9 * -0.8; 5.0 (<0.01)
RO 1980 2009 3.3 6.6 0.6 -1.2; 2.5 (0.50)
AC 1980 2009 2.2 1.2 -0.9 -3.0; 1.2 (0.40)
AP 1980 2009 13.4 5.1 -2.8 * -4.3; -1.3 (< 0.01)
RR 1981 2009 0.1 15.4 5.3 * 0.1; 10.8 (0.04)
TO 1989 2009 0.1 8.1 8.9 * 5.9; 12.0 (< 0.01)
BA 1980 2009 3.7 4.3 0.4 -0.1; 0.8 (0.08)
RN 1980 2009 6.3 5.1 -1.0 * -1.8; -0.3 (0.01)
MA 1980 1999 3.6 3.7 1.1 * 0.0; 2.2 (0.04) 1999 2009 3.7 10.8 9.8 * 6.7; 13.0 (< 0.01)
PI 1980 1993 3.3 3.3 -4.0 * -7.6; -0.3 (0.03) 1993 2009 3.3 8.3 6.6 * 3.8; 9.6 (< 0.01)
PB 1980 1999 2.7 1.5 -2.1 -4.3; 0.2 (0.07) 1999 2009 1.5 4.2 12.4 * 5.9; 19.3 (< 0.01)
AL 1980 1997 7.2 2.1 -5.0 * -7.2; -2.8 (< 0.01) 1997 2009 2.1 5.8 6.0 * 1.9; 10.2 (< 0.01)
SE 1980 2009 7.9 5.7 0.7 -0.9; 2.3 (0.38)
CE 1980 1985 3.5 2.2 -8.5 -16.7; 0.5 (0.06) 1985 2009 2.2 6.0 4.2 * 3.3; 5.1 (< 0.01)
PE 1980 2009 6.2 5.7 0.3 -0.1; 0.7 (< 0.12)
APC: annual percent change; 95%CI: 95% confi dence interval
* Statistically signifi cant; p < 0.05.
Note: standardized mortality rate per 100,000 women.
AC: Acre; AL: Alagoas; AM: Amazonas; AP: Amapá; BA: Bahia; CE: Ceará; DF: Federal District; ES: Espírito Santo; GO: Goiás; MA: Maranhão; 
MG: Minas Gerais; MT: Mato Grosso; MS: Mato Grosso do Sul; PA: Pará; PB: Paraíba; PE: Pernambuco; PI: Piauí; PR: Paraná; RJ: Rio de Janeiro; 
RO: Rondônia; RN: Rio Grande do Norte; RS: Rio Grande do Sul; RR: Roraima; SC: Santa Catarina; SE: Sergipe; SP: São Paulo; TO: Tocantins.
Discussion
From 1980 to 2009, there was a sharp disparity in 
cervical cancer mortality among Brazilian wom-
en. These findings mirror the country’s socioeco-
nomic inequalities. It is widely acknowledged 
that access to primary care and Pap test coverage 
is lower among women with lower socioeconom-
ic status 18,19. There is no precision related to ac-
cess to diagnosis and treatment for these women, 
since mortality coefficients are heterogeneous in 
the various regions of Brazil.
The distribution of the hierarchical levels of 
care within Brazil’s territory is unequal, showing 
a disparity between areas that have a well-struc-
tured urban network (in the Central and South-
ern regions), with the presence of well-fitted lev-
els of care situated at regular intervals, and areas 
with an absence of some intermediate hierarchi-
cal levels (in the North and Northeast). The North 
and Central-West regions have a scarce health 
care system, where there is sparse occupation of 
the territory. Despite the consolidated occupa-
tion of the Northeast, cities there traditionally 
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concentrate the supply of equipment and servic-
es, and there are few cases of intermediate level 
healthcare centers 20.
According to this study’s findings, the Cen-
tral-West, Southeast, and South of Brazil show 
a drop in cervical cancer mortality, while the 
North and Northeast show an upward trend. The 
States display the same heterogeneous profile, 
with the worst situations in Paraíba, Maranhão, 
and Tocantins, which rank low in human devel-
opment, while the States with a higher human 
development index (HDI) showed a downward 
trend in mortality. Cervical cancer is in fact 
the most frequent type of cancer in the North 
(24/100,000). It ranks second in the Central-West 
(28/100,000) and Northeast (18/100,000), third 
in the Southeast (15/100,000), and fourth in the 
South (14/100,000) 21.
Specifically in the Central-West region, the 
Federal District shows downward cervical cancer 
mortality coefficients, while the rates practically 
stabilized in São Paulo and Rio de Janeiro. The 
level of development appears to be proceeding 
quite well in the Federal District, seat of the na-
tional capital, Brasilia. Meanwhile the South of 
Brazil showed a clear downward trend in all the 
States beginning in the year 2000.
These findings are consistent with the litera-
ture, since high cervical cancer mortality rates are 
expected in less developed regions. Meanwhile, 
there has been an important drop in mortality 
from this neoplasm in recent decades in devel-
oped countries like Finland, Iceland, Belgium, 
Scotland, and the United Kingdom, especially 
since the introduction of screening programs in 
the 1960 and 70s. Importantly, the above-men-
tioned countries have had organized cervical 
cancer screening programs for at least three de-
cades 22,23.
Although the current study’s findings point to 
high cervical cancer mortality in the North (9.9) 
and Central-West (8.6) of Brazil, the rates are low 
as compared to other Latin American countries 
such as Venezuela (15.2), Ecuador (18.6), Bolivia 
(22.2), Nicaragua (26.1) and Haiti (53.3) 24.
It is important to highlight the difficulties in 
obtaining a completely reliable scenario for can-
cer mortality in these countries, including Bra-
zil. Although a population-based cancer registry 
was launched in recent years, there are persis-
tent difficulties in producing high-quality data. 
Many cases of cervical cancer are still reported 
as “cancer of the uterus, part unspecified” 25. 
Due to these factors, a correction method was 
recently suggested for these data based on un-
derreporting, in which rates of 4.6 and 5.1 deaths 
per 100,000 women were reported from 1996 to 
2005 in Brazil. However, the correction increased 
these values by 103.4% 26. Another possible ex-
planation for the observed disparity in cervical 
cancer mortality rates among Brazilian women 
could be the variation in exposure to risk factors 
and diagnostic practices.
Although mortality data in Brazil have im-
proved in the majority of the States 11,13, only the 
Federal District and the States of Rio de Janeiro 
and São Paulo were classified as having “good” 
quality data in 2000. The other States of the South-
east had “satisfactory” data; those of the Central-
West improved from “fair” to “satisfactory”. Many 
States of the North and Northeast had no better 
than “fair” data, and some remained “deficient” 
13. Thus, the findings for the Northeast should 
be interpreted with caution. In this sense, reli-
ability and validity issues should be considered 
in the estimates of the Brazilian population, in 
addition to the limitations in the information on 
death, which can create biases in the mortality 
rates, particularly in women living in the North 
and Northeast regions of the country 12,27.
The year 2012 witnessed the publication of 
the document Brazilian Guidelines for Cervical 
Cancer Screening, with recommendations that 
incorporate the needs of various segments of so-
ciety and that are feasible and usable by health 
centers and professionals 21. According to the 
National Cancer Institute (INCA), in 2012 in Bra-
zil the Pap smear test was the priority screening 
strategy recommended by the Ministry of Health 
for women 25 to 59 years of age. An estimated 
80% reduction in mortality from cervical cancer 
could be achieved by screening women in the 25 
to 65-year age bracket with the Pap smear test 
and treatment of precursor lesions with a high 
potential for malignancy, or in situ carcinoma. 
This would require organization, comprehen-
siveness, and quality in the screening program, 
as well as follow-up of patients 21.
Furthermore, the Brazilian health system has 
low capacity for cervical cancer diagnosis. Proper 
capacity requires adequate collection of mate-
rial from the uterine cervix for oncologic cytology 
(Papanicolaou), but especially the ability of the 
service to supply the test results 25,26. According 
to a survey of 89 hospitals and seven chemo-
therapy or radiotherapy services affiliated with 
a High Complexity Oncology Center (CACON), 
from 1995 to 2002, 45.5% of women presented 
cervical cancer in stages III or IV at the time of di-
agnosis 28. These data reflect problems in access 
to services and especially the lack of oncology 
centers outside the State capitals.
Finally, it is important to recall that cancer of 
the uterine cervix is among those with the great-
est potential for cure and prevention when diag-
nosed early. The data presented here may be con-
TRENDS IN CERVIX CANCER MORTALITY 607
Cad. Saúde Pública, Rio de Janeiro, 29(3):599-608, mar, 2013
sidered indicators for cervical cancer control in 
Brazil. They should certainly contribute to better 
planning of health actions, support, surveillance, 
and evaluation of interventions 29. Such results 
highlight the importance of priority-setting in 
primary and secondary prevention in less devel-
oped regions of the country. Thus, the current 
study’s importance lies in having discussed the 
current state of cervical cancer mortality in the 
States of Brazil while providing information that 
can be useful in other countries.
Limitations
The use of mortality data from the SIM is con-
ditioned on corrections due to the frequent un-
dercounting of deaths in less developed areas. 
Importantly, the study excluded death records 
with the individual’s age missing. Thus, the data-
base may display sources of imprecision that are 
inherent to data collection, or to the methodol-
ogy used to prepare population estimates. Mean-
while, use of the cervical cancer mortality rate is 
limited whenever there are a high proportion of 
deaths without medical care or due to ill-defined 
causes.
Resumen
El objetivo fue analizar la mortalidad por cáncer de 
cuello de útero en Brasil, en sus macrorregiones y esta-
dos en el período de 1980 a 2009. Se trata de un estudio 
ecológico de serie temporal, con uso de información 
sobre óbitos del Sistema de Información sobre Morta-
lidad (SIM), y base demográfica del Instituto Brasileño 
de Geografía y Estadística (IBGE). Se realizaron aná-
lisis de las tendencias de la mortalidad, mediante la 
regresión de Poisson. En Brasil se observó la estabili-
zación en las tasas de mortalidad. En las macrorre-
giones, hubo caída en el Sur ( 4,1%), Sudeste ( 3,3%) y 
Centro-Oeste ( 1%); aumento en el Nordeste (3,5%) y 
Norte (2,7%). En los estados, las principales caídas 
fueron observadas en São Paulo ( 5,1%), Rio Grande 
do Sul, Espírito Santo y Paraná ( 4%). Los mayores au-
mentos se observaron en Paraíba (12,4%), Maranhão 
(9,8%) y Tocantins (8,9%). Conclusión: Brasil presen-
ta estabilización en las tasas de mortalidad. No obs-
tante, hubo una reducción en 3 macrorregiones y en 
10 estados, mientras que en 2 macrorregiones y en 10 
estados la mortalidad sigue aumentando. Una de las 
razones para esa disparidad puede ser el menor acceso 
al tratamiento para las pacientes de áreas menos de-
sarrolladas.
Neoplasias del Cuello Uterino; Mortalidad; 
Tasa de Mortalidad
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